Zhejiang Medicine exhibits notable earnings growth due to bu...
Zhejiang Medicine exhibits notable earnings growth due to business reinvestment, despite a low return rate. Effectively managing its retained profits (69%), the company's earnings are expected to accelerate according to analysts.
Zhejiang Medicine Co., Ltd.'s (SHSE:600216) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3707Followers
0Following
8606Visitors
Follow